Isolation and antifungal sensitivity to Candida isolates in young females

Central European Journal of Medicine

Volumn 6, Issue 2, 2011, Pages 172-176

  Adesiji, Y O ^a   Ndukwe, N ^b   Okanlawon, B M ^b  

^a Department of Medical Microbiology and Parasitology ^*  (Nigeria)

^b LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Antifungal sensitivity tests; Candidiasis epidemiology; Nigeria; Young female

Indexed keywords

FLUCONAZOLE; NYSTATIN; VORICONAZOLE;

ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASYMPTOMATIC INFECTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FUNGUS ISOLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SPECIES DISTRIBUTION; UTERINE CERVIX CYTOLOGY; VAGINA CANDIDIASIS;

EID: 79956344537     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-010-0071-0     Document Type: Article

References (23)

1. Nwokedi E, Omole-Ohonsi A (2007): Current Clinical Review of Vulvovaginal Candidiasis (VVC). Journal of Medicine and Rehabilitation: 1: 28-32
2. Onifade AK, Olorunfemi OB (2005): Epidemiology of Vulvo-vaginal Candidiasis in Female Patients in Ondo State Government Hospitals. International Journal of Food, Agriculture and Environment: 3: 118-119
3. Sexually transmitted diseases treatment guidelines (2006): Centers for Disease Control and Prevention. MMWR Recomm. Rep. 55(RR-11): 1-95
4. Sobel J, Chaim W, Nagappan V, Leaman D (2003): Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 189: 1:297-300
5. Sobel JD (1998): Vulvovaginitis due to Candida glabrata. An emerging problem. Mycoses 41 (suppl. 2): 18-22 (Pubitemid 29104114)
6. Gygax S.E, Vermitsky JP, Chadwick SG, JS Matthew, J A. Zimmerman, E Mordechai, M E. Adelson, 3 and J P. Trama: Antifungal Resistance of Candida glabrata, Vaginal Isolates, and Development of a Quantitative Reverse Transcription-PCR-Based Azole Susceptibility Assay Antimicrobial Agents and Chemotherapy, 2008: 52(9): 3424-3426
7. Ribeiro M, Dietze R, Paula C, Da-Matta D, Colombo A (2000): Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia 15: 5-10
8. Arthington-Skaggs B, Motley M, Warnocks D, Morrison C (2000): Comparative Evaluation of PASCO and National Committee for Clinical Laboratory Standards M-27-A Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Yeast. J. Clin. Microbiol. 38: 2254-2260. (Pubitemid 30414347)
9. Clinical Laboratory Standards Institute (2007): Reference Method for Disc diffusion Antifungal Susceptibility of yeasts Approved standard M- 44-A. CLSI, Villanova, PA, USA
10. Howard L (1991): Epidemiology of Vagintis. American journal of Obstetrics and Gynaecology, 165: 1168-1176
11. Enweani IB, Ogbonna CI, Kozak W (1987): The incidence of candidiasis amongst the asymptomatic female students of the University of Jos, Nigeria. Mycopathologia. 99: 123-141
12. Ako-Nai AK, Kassim OO, Adeniram MO, Taiwo O (1993): A study of urinary tract infections at Ile lfe, Nigeria. East African Med J. 70: 19-14
13. Vermitsky JP, J Matthew . G. S. Sean. J. P. Chadwick .M. E Trama, A, E Mordechai and S.E. Gygax(2009): A Survey of Vaginal-flora Candida species of Different Age Groups Using species-specific PCR Detection. J. Clin. Microbiol. doi:10.1128/JCM.02485-07
14. Watson C and Calabretto H (2007): Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis. Austr. J Obstet Gynecol. 47: 262-272 (Pubitemid 47079552)
15. Solanki A, Mathur D, Joshi K (1983): Bacterial, fungal and parasitic flora in vaginitis. J Indian Med Assoc 1983; 81 : 151-3
16. Holland J, Young M, Lee O, Chen S (2003): Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect 2003; 79 : 249-50 (Pubitemid 36723971)
17. McCormack WM, Starko KM, Zinne SH (1998): Symptoms associated with vaginal colonization with yeast. Am. J. Obstet. Gynecol. 158: 31-33
18. Enweani IB, Gugnani H, Okobia R, Roseline Okobia, Ojo SB(2001). Effects of contraceptives on the prevalence of vaginal colonization with Candida species in Edo State. Microbiol 18: 171-173 (Pubitemid 34116637)
19. Kikani BA, Kikani KM, Pathak SJ (2008): Effects of chemically synthesized azole compounds on clinical isolates of Vaginal Candidiasis, in comparison with commercially available drugs. The internet journal of Microbiology. 4-2
20. Okungbowa FI, Isikhumhen SO, Dede PO (2003): The distribution frequency of Candida species in the genitourinary tract among symptomatic individuals in Nigerian Cities. Micrologia 20: 60-63 (Pubitemid 37408421)
21. Koutsoukou A, Stylianakis A, Tsiplakou S, Tachtatzis M., Tsakona E., Vourtsi A., Sideri A (2005): A 3-year study of resistance of candida pathogens obtained from patients with fungemia with emphasis to new antifungal agents. Athens Med J. p 1228
22. Cruz O, (2003): Species distribution and antifungal susceptibility profile of Candida spp. Bloodstream isolates from Latin American Hospitals. J. Clin. Microbiol; 98: 401-5
23. Ferris D, Nyorjesy P, Sobel J, Soper D, Pavletio A, Litaker M (2002): Over the counter antifungal drug misuse associated with patient diagnosed vulvovaginal candidiasis. Obstet Gynecool: 99: 419-425 (Pubitemid 34188402)